EquipNet India Celebrates 10 Years
EquipNet India, a subsidiary of EquipNet, a laboratory equipment supplier, celebrated its 10th anniversary in the surplus asset management market.
On Sep. 18, 2017, EquipNet India, a subsidiary of EquipNet, a laboratory equipment supplier, celebrated its 10th anniversary in the surplus asset management market. The Indian subsidiary has been operating from its Mumbai headquarters since 2007.
“Surplus asset management is being recognized as increasingly critical, and many companies realize that they do not have the resource or skill base to tackle the issue in-house,” said Krishnamoorthy Vishwanathan, managing director of EquipNet India, in a company press release. “Choosing when to invest internal resources in a specific activity and when to seek external help is a tough, but essential, management task. Defining and focusing on core company strengths and recognizing the need for expert support in other areas will ensure operational efficiency and can have a major impact on the bottom line.”
According to an IBEF report, the Indian market has experienced an almost 8% growth rate from 2016 to 2017. By 2020, it is estimated that India will become the fifth largest manufacturing country in the world, creating 100 million new jobs by 2022.
Source: Equipnet
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Entering New Domains for 3D Printing of Drug Products
April 6th 20253D printing of personalized medications is currently possible under existing compounding regulations, offering enhanced process control through automation. But new legislation coming in 2025 will allow 3D printing as part of a distributed manufacturing framework.
